While none of the eight European countries (or Canada) in Table 1 suffer from widespread NTDs, all of the Latin American nations listed, as well as the African Catholic countries and the Philippines, are highly endemic for such conditions. Together, these 22 nations comprise a significant percentage of the world's NTDs (Table 1), including almost 100% of the Chagas cases, which are found overwhelmingly in Latin America [5], and 21%–27% of the world's intestinal helminth infections, led by Brazil in Latin America, the Philippines in Asia, and DRC in sub-Saharan Africa [6], [7]. The 22 most populous NTD-endemic Catholic countries also account for 14%–16% of the world's 207 million cases of schistosomiasis [8], [9], and lymphatic filariasis (LF), onchocerciasis, or both of these infections are transmitted in 13 of the 22 nations [10], [11].

A critical policy implication of these findings is that the major Catholic charities and perhaps even the Catholic Church has a unique opportunity to promote NTD control in several of the 22 most endemic Catholic majority countries. Today, several Catholic charities are making significant contributions to global public health, including efforts to promote “deworming”, i.e., mass drug administration for human intestinal helminth infections. Catholic Relief Services has assisted poor and vulnerable populations for over 60 years [12], [13], with specific efforts to provide deworming treatments for school-aged children in Benin [14], Ghana [15], and presumably elsewhere in over 30 African countries where they work [16], while also operating community health programs in 26 countries that serve 3.5 million people [17]. Similarly, the Catholic Medical Mission Board, which was founded in 1928 by Dr. Paluel Flagg after a visit to Haiti to help leprosy patients, has provided support to health care programs in developing countries since 1966 and today distributes hundreds of millions of dollars worth of medicines annually [18]. Many local archdioceses, including the Roman Catholic Archdiocese of Manila through its Caritas Manila program, for example, also provide deworming treatments [19]. Of interest is the finding that many Catholic organizations operate in countries both with and without Catholic majority populations, recognizing health as a fundamental right for people of all denominations [16], [17].

The important work of the major Catholic charities and the Church could ultimately be expanded to support national programs of NTD control and elimination. Currently, the United States Agency for International Development (USAID) is supporting integrated control of the seven most common NTDs through low-cost packages of essential medicines in 14 countries including four of the 22 listed in Table 1, i.e., DRC, Haiti, the Philippines, and Uganda [20], while the British Department for International Development (DFID) is also supporting additional African countries [21]; both agencies are planning to expand their NTD control activities in the coming years. Additional countries, including Burundi, are being supported through Legatum, Geneva Global, and the Global Network for NTDs [22].

In an earlier Editorial, I pointed out that it is unreasonable to expect the United States and the United Kingdom to shoulder the entire burden of global NTD control and that we must look to other European countries, the Gulf Cooperation Council, and even some emerging economies for development assistance on this front [23]. But, in addition, the major Catholic charities and the Catholic Church could re-organize some of their advocacy and resource mobilization programs to combat NTDs among the world's poorest Catholics, including national control programs in the 17 countries not currently supported by USAID, DFID, or the Global Network for NTDs. Efforts could include partnerships with the major Catholic majority endemic countries in Latin America, Africa, and the Philippines. Through mass administration with a package of preventive chemotherapy drugs costing as little as US$0.50 annually [24], [25], such global action could directly benefit the 100–200 million Catholics suffering today from intestinal helminth infections, the roughly 30 million with schistosomiasis, and tens of millions with LF and/or onchocerciasis. Today, the so-called rapid impact packages of NTD control medicines are considered among the lowest cost interventions in all of global health, and one of the most cost-effective [1], [25]. Partnerships with the Catholic Church or charities could also help to reduce the global disease burden of Chagas disease, which, because it is found almost exclusively found in the countries of Latin America, is largely a disease of Catholics, as well as selected indigenous groups [5].

The Catholic Church has also supported scientific research and development in tropical medicine, beginning with the origin of the antimalarial drug, quinine, from “Jesuit's bark” or “Jesuit's powder” [26], [27]. Today, Rev. Thomas Streit, CSC, from the University of Notre Dame, is leading efforts to eliminate LF through mass drug administration in Haiti [28]. Science-based institutions such as the Pontifical Academy of Sciences founded by Pope Pius XI in the 1930s [29] could also provide important guidance for NTD research and new product development.

Expanded global public health efforts through programs of national control, stepped-up advocacy, and resource mobilization efforts by the major Catholic charities, nongovernmental development organizations affiliated with the Church, and of course the Holy See, could ultimately lead to reductions of one-quarter of the world's intestinal helminth infections, 15% of the world's schistosomiasis, and much of the world's Chagas disease. At a modest cost of between US$50 and US$100 million annually, such global action would establish an amazing legacy for health and economic development by and for the global Catholic community.